IL22 and urinary bladder neoplasm: These intratumoral group 1 ILCs are associated with higher bladder tumor stage and exhibit a Th17‐like differentiation phenotype, marked by high expression of RORγt, IL‐17, and IL‐22 and low expression of Th1 and Th2 transcription factors and cytokines.